Antimicrobial utilization and susceptibility patterns of a sentinel group of bacterial isolates prior and subsequent to the introduction of Ertapenem to the hospital formulary  by Araujo, J. et al.
trac
2
t
m
s
(
c
c
u
T
o
g
a
i
d
2
A
s
t
l
J
R
L
1
S
2
d
c
c
e
b
i
s
A
P
t
s
r
c
b
1
P
a
1
t
m
t
t
r
r14th International Congress on Infectious Diseases (ICID) Abs
screened by PCR analysis with primers speciﬁc for 6 car-
bapenemase genes. Ampliﬁcation products were sequenced
to determine the gene present.
Results: Twelve of the 15 patients studied were hospi-
talizated at the ICU. The most frequent sites of isolation
were the respiratory tract (16) and the blood (11). With the
exception of colistin (0% resistance) there were no antibi-
otics with good activity against these isolates. Of the other
antibiotics tested, tigecycline showed the best activity with
an MIC90 value of 2 mg/L. The genotypic study revealed
that the same strain was responsible for all the infections.
All the isolates harboured the bla-OXA-51—like gene and the
6 of them chosen to sequence the gene were identical and
100% homologous with the bla-OXA-66 gene. PCR showed
that the insertion sequence ISAba1 was present upstream of
the oxacillinase gene in all the isolates.
Conclusion: a) Molecular typing revealed that the out-
break detected in our hospital was due to a single A.
baumannii clonal group. b) The epidemic strain of A. bau-
mannii produces an OXA-66-ISAba1 carbapenem-hydrolyzing
oxacillinase. c) Even though the outbreak was controlled,
and the number of isolates decreased signiﬁcantly, the clone
responsible of the outbreak persisted at the hospital during
the following year.
doi:10.1016/j.ijid.2010.02.1582
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Online games teaching children hygiene and antibiotic
resistance: Evaluation of the e-Bug games
D. Farrell 1, P. Kostkova1,∗, J. Weinberg1, D. Lecky2, C.
McNulty2
1 City University, London, United Kingdom
2 Health Protection Agency, Gloucester, United Kingdom
Background: e-Bug is a EC-funded antibiotic, hygiene
teaching resource aiming to reinforces an awareness of
microbes, respiratory hygiene and prudent antibiotics use
among junior and senior school children across Europe. e-
Bug junior web games were developed for children age 9-12
years. The e-Bug junior game has a number of ‘‘levels’’
teaching the given set of learning outcomes (LOs). Player,
shrunken inside human body, interacts with good and bad
cartoon microbes (Fig 1) as well as antibiotics and viruses.
Teaching the LOs is implemented through interaction with
microbes (making yogurt (Fig 3), ﬁnishing course of antibi-
otics (Fig 2). Knowledge is tested seamlessly before and after
each level in a Game Show style similar to the game ‘‘Do you
want to be a Millionaire?’’
Methods: Evaluation was primarily conducted in the UK
and online demonstrating statistically signiﬁcant knowledge
gain of the learning outcomes. This was complemented
by focus groups and observational studies with 29 pupils
taking part (and fully completing the pre and post question-
naire) from three schools. Before playing the game, only 4
pupils ‘‘agreed’’ that fungi were microbes while after play-
ing 18. Smaller improvements were seen in other questions
including: ‘‘We use microbes to make things like bread and
yogurt’’ (11 correct before, 23 correct after) and ‘‘Soap can
be used to wash away bad bugs’’ (20 before vs 24 after)
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Results: The main evaluation took place in May — August
009. Each of the completed levels was evaluated for sta-
istical signiﬁcance of knowledge change of the LOs. As
any questions were correct before and after the game, the
tatistically signiﬁcant improved responses were measured
using McNemar’s test), for the following questions: ‘‘if you
annot see a microbe it is not there’’, ‘‘most coughs and
olds get better without medicine’’ and in particular ‘‘we
se good microbes to make things like bread and yogurt’’.
here was a trend towards improved knowledge however in
ther questions did not reach statistic signiﬁcance
Conclusion: The study demonstrated that computer
ames can teach children about hygiene and antibiotics in
n enjoyable way. Further study is needed to evaluate an
mpact on behaviour change
oi:10.1016/j.ijid.2010.02.1583
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ary
. Araujo1,∗, C. Rodrguez-Osorio1, E. Criollo-Mora1, A.
amos-Hinojosa1, A. Macías Hernandez2, A. Ponce-de-
eon1, J. Sifuentes-Osornio1
INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION
ALVADOR ZUBIRAN, TLALPAN, Mexico
National Institute of Medical Sciences, Mexico City, Mexico
Background: It has been suggested that after the intro-
uction of ertapenem into hospital use, the amount of other
arbapenems and the rate of resistance to other antimi-
robials decreases. We conducted a retrospective study to
valuate these outcomes.
Methods: We studied 48 months (two 24 month-periods)
efore (PRE) and after (POST) the introduction of ertapenem
n August 2004. Antibiotic use was determined using the
tandard deﬁned daily dose (DDD) per 1000 patient/days.
ntimicrobial susceptibility testing to Escherichia coli,
seudomonas aeruginosa, Klebsiella pneumoniae and Acine-
obater baumanii was performed with the Vitek automated
ystem. We used chi-square for trend to compare rates of
esistance and changes in antimicrobial use.
Results: In the PRE-period, we analyzed 4072 E.
oli, 677 P. aeruginosa, 571K. pneumoniae, and 67 A.
aumanii isolates; in the POST 4648, 884, 559, and
09, respectively; antibiotic consumption was as follows:
RE-period: meropenem 89.9 DDD/1000/patients/days,
ntipseudomonal cephalosporins 90.9, and ceftriaxone
95.65; POST period: 75.3, 103.58, and 184.77, respec-
ively. The rate of antimicrobial susceptibility was: E. coli, to
eropenem in PRE-period 99.6% and in POST-period 98.05%,
o ceftazidime 88.67% and 84.75% (p < 0.000), respectively;
o P. aeruginosa, meropenem 67.41% and 61.74% (p = 0.004),
espectively, ceftazidime 63.74% and 62.12% (p = 0.3388),
espectively, and piperacillin/tazobactam 69.17% and
7.21%(p = 0.15), respectively; K. pneumoniae, meropenem
00% and 98.7% (p < 0.05), respectively, and ceftazidime,
6.60% and 90.29% (p = 0.018); A. baumanii, meropenem
5.2% and 79.09% (p = 0.08), respectively, and ceftazidime
6.14% and 58.88% (p = 0.12), respectively.
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Conclusion: Our data show that after the inclusion of
rtapenem, the use of other carbapenems and ceftriaxone
igniﬁcantly decreased, however the use of antipseu-
omonal cephalosporins signiﬁcantly increased; of note,
here was a slight decrease in the susceptibility to car-
apenems and broad-spectrum cephalosporins during the
OST-period, which could be attributed to the intensive use
f both, ceftriaxone and antipseudomonal cephalosporins.
oi:10.1016/j.ijid.2010.02.1584
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linical characterization of patients with carbapenem-
esistant versus carbapenemsusceptible Acinetobacter
aumannii infections
. Tyagi ∗, J. Koirala
Southern Illinois University School of Medicine, Springﬁeld,
L, USA
Background: Steady rise in carbapenem resistance in
cinetobacter baumannii has become a major challenge for
linicians. The objective of this study is to characterize
linical features of infections secondary to carbapenem-
esistant organisms compared to carbapenemsusceptible
rganisms.
Methods: We conducted a retrospective analysis of data
or 39 patients from two tertiary care medical centers
ho had positive cultures for A. baumannii. Collected
ata included clinical presentations, underlying illnesses,
reatment course, clinical outcome, microbiological data
nd other laboratory data. Statistical comparisons were
one between patients infected with carbapenem-resistant
CRAB) and carbapenem-susceptible (CSAB) isolates using
isher’s exact test and Student’s T-test. Multidrug resistance
MDR) was deﬁned as resistance to more than two classes of
ntibiotics generally active against A. baumannii.
Results: Total 17 (44%) patients had carbapenem-
esistant (CRAB) and 24 (62%) had multidrug resistant (MDR)
. baumannii. Mean age (53± 5.7 years) and male predom-
nance (70%) were comparable in both groups. Predisposing
actors included diabetes mellitus (15), pressure ulcers (12),
alignancy (8), paraplegia (7), burn (5), peripheral vascu-
ar disease (5), and chronic renal failure (5). Majority of the
nfections involved wound (13) and bone (10) followed by
putum (8), urine (5) and bloodstream (3). Mean duration for
rst positive A. baumannii cultures after admission to the
ospital was 6.6 (±3.4) days. Patients infected with CRAB
ad signiﬁcantly higher rates of respiratory or other organ
ailures (47% vs. 14%, p < 0.05), and were more frequently
dmitted to the intensive care unit (53% vs. 18%, p < 0.05),
ompared to the patients with CSAB. Patients with CRAB
ere also more likely to be admitted for prolonged dura-
ions in the hospital (mean = 31.5 vs. 8.5 days, p < 0.01) and
n the intensive care unit (mean = 25.9 vs. 1.2 days, p < 0.05).
ortality was signiﬁcantly higher among patients with CRAB
ompared to those with CSAB (29% vs. 4.5%, p < 0.01). A.
aumannii infections were treated for an average duration
f 24 (±7) days. Antibiotics used for treatment included
arbapenems, ampicillin-sulbactam, tigecycline, aminogly-
osides, colistin and polymyxin B.
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Conclusion: Carbapenem-resistant A. baumannii infec-
ions were associated with severe morbidity, requiring
rolonged hospitalization and ICU admissions, and also
esulted in increased mortality.
oi:10.1016/j.ijid.2010.02.1585
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oxycycline modify the cytokine storm in patients with
engue and dengue hemorrhagic fever
. Zavala Castro1,∗, T. Fredeking2
Universidad Autonoma de Yucatan, Merida, Yucatán, Mex-
co
Antibody Systems Inc., Hurst, TX, USA
Background: Dengue virus infection is an acute febrile
isease caused by a virus of the genus Flavivirus, family
laviridae. Usually is a mild self-limiting acute illness, but
ay evolve to a hemorrhagic form characterized by plasma
eakage and hemorrhagic manifestations. The treatment of
oth forms has been limited to the management of the signs
nd symptoms, and sometimes a retroviral treatment has
een used. The cytokine cascade has a crucial role in the
athogenesis of dengue (DF) and dengue hemorrhagic fever
DHF), and the presence of the Th1 and Th2 cytokines are
esponsible to cross-regulate the disease from a mild illness
DF; Th1-type response), to a severe illness (DHF; Th2-type
esponse). Recently, doxycycline was show to inhibit the
ytokine storm caused by Staphylococcal exotoxins, speciﬁ-
ally the cytokines involved in the Th2-type response. In this
ork, we use the doxycycline and tetracycline treatment in
atients with dengue and dengue hemorrhagic fever, in order
o regulate the Th1 and Th2 cytokines.
Methods: Thirty patients were included in the work.
he patients were divided in groups of 5 each: DF, DF+
oxycycline, DF+ tetracycline, DHF, DHF+ doxycycline, DHF+
etracycline. The doxycycline groups were treated with
ral doxycycline 200mg/day/7 days, the tetracycline groups
ere treated with oral tetracycline 1.5 g/day/7 days. The
atients were bleeding in days 0, 3 and 7. Serum concen-
rations of IL-6, IL-1, IL-1ra, TNF-, and sTNF-R1 were
etermined by ELISA. Clinical laboratory were performed
ith each bleeding, and a clinical control of signs and symp-
oms were carry out every day.
Results: Doxycycline groups shows the higher immune-
egulation of cytokines IL-6, IL-1, and TNF-, with an
ncrease in the levels of IL-1ra and sTNF-R1, followed by
he tetracycline groups which presents an slightly higher
egulation than the control group without treatment. The
mprovement of the patients was better in the doxycycline
roups, with a faster remission of the symptoms than the
ther groups.
Conclusion: The use of doxycycline in the treatment of
engue and dengue hemorrhagic fever patients could regu-
ate the cytokine cascade and improve the recovery of the
atients with dengue and dengue hemorrhagic fever.
oi:10.1016/j.ijid.2010.02.1586
